Healthcare Unfiltered cover image

For Blood and Money: A Biotech Story

Healthcare Unfiltered

00:00

Biotech - What Do You Do When Your Biggest Product Is a Generic?

Abhi bought 50% of one blood cancer drug, Brütneb for $21 billion. That implication is that the drug itself at the time was worth $42 billion. It's almost hard to fathom. I think it was the peak of the biotech boom,. Here you had Abhi purchasing pharmaceuticals, which owned 50%. Remember, not the whole thing; we're talking about a very large conglomerate.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app